Skip to main content

Practice Management

Practice Management

Managed Care and Medicare Use of Generics: Seizing the Opportunity, Part 2

Gary M. Owens, MD

Practice Management

Trends in Pharmaceutical Expenditures: The Impact on Drug Benefit Design

Joanne LaFleur, PharmD, MSPH, Leslie Fish, PharmD

Stakeholder Perspective

Drug Expenditures' Impact on Benefit Design

by F. Randy Vogenberg, PhD, FASHP

Practice Management

Medicare Coverage for Erythropoiesis-Stimulating Agents: The Perfect Storm

Stakeholder Perspective

UnitedHealthcare's Response to the ESA Debate

by Lee Newcomer, MD

Practice Management

Comparing Pharmacy Benefit Managers: Moving Well Beyond the Simple Spreadsheet Analysis

David Calabrese, RPh, MHP

Stakeholder Perspective

Maximizing Savings, Efficiency, and Quality when Contracting with a PBM

by Thomas McCarter, MD, FACP

Practice Management

Where Generics and Biologics Meet

Melisa J. Heinrichs, PharmD, BSPS, Gary M. Owens, MD

Practice Management

The NCCN Compendium for Cancer Management

Stakeholder Perspective

Economic/Societal Costs of Adding a Compendium to the Federal Registry

by Thomas Kaye, RPh, MBA, FASHP

Practice Management

Patent Reform Proposals Raise the Stakes for Researchers, Manufacturers of Biologics

Shayna B. Kravetz, BSc, Rosemary Frei, MSc

Stakeholder Perspective

AHDB Stakeholder Perspective

by Thomas McCarter, MD, FACP

Practice Management

The Value of Biologics

Stakeholder Perspective

Value-Based Benefit— A Joint Effort

Practice Management

Kaiser Daily Health Policy Report

Practice Management

National Asthma Guidelines Updated

Page 26 of 32
Results 251 - 260 of 318